Cream showdown: aquaphor vs miaderm for radiation burns
NCT ID NCT05340673
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two creams, Aquaphor and Miaderm, to see which one better treats skin irritation caused by radiation therapy in breast cancer patients. About 208 women with early-stage breast cancer will use one of the creams during their radiation treatment. The goal is to find out which cream reduces redness, itching, and pain more effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST DUCTAL CARCINOMA IN SITU are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fasting during chemo: a new way to boost treatment?
- Could a common cholesterol drug boost breast cancer treatment?
- Gene test could guide breast cancer treatment to boost survival
- One-Week radiation for breast cancer: MRI precision may cut side effects
- Could a single day of radiation replace weeks of treatment for breast cancer?
- Radiation may offer better quality of life than hormone pills for older breast cancer patients